U.S. Disinfecting Cap Market is Expected to be Flourished by Growing Hygiene Concerns due to Pandemics
![]() |
U.S. Disinfecting Cap Market |
The
U.S. disinfecting cap market is primarily driven by rising use of injection
vials and accessories across major end use industries such as pharmaceutical,
biotechnology, and medical devices. Disinfecting caps provide airtight and
sterile sealing to injection vials, hence preventing external contamination.
These caps employed nano-silver technology that acts as an effective
antimicrobial agent to inhibit the growth of several microbes including
bacteria, fungi, and viruses on the cap surface for extended duration. With
growing hygiene concerns due to pandemics, demand for disinfecting caps from pharmaceutical
manufacturers is expected to increase significantly during the forecast period.
The global U.S. disinfecting cap market is estimated to be valued at US$ 534.1
Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market Dynamics:
The two key drivers aiding the growth of the U.S. disinfecting cap market are
growing hygiene concerns due to pandemics as mentioned in the heading and
significant investments in pharmaceutical and biotechnology R&D. The
ongoing Covid-19 pandemic has accentuated the need for advanced medical
equipment with enhanced safety and sterilization features. This is encouraging
pharmaceutical companies to increasingly adopt disinfecting caps for primary
packaging. Moreover, substantial investments by both public and private players
in drug development, plasmid DNA manufacturing, cell and gene therapy research
are driving the demand for disinfecting vials and caps from end use industries.
Nano-silver coated disinfecting caps effectively inhibit microbial growth on
caps, maintaining the sterility of injection vials over extended shelf life.
This unique feature is attracting more pharmaceutical manufacturers to opt for
disinfecting caps.
Segment Analysis
The U.S.
Disinfecting Cap Market Demand is dominated by the hospitals segment
which holds around 65% share. Hospitals conduct a large number of treatments
involving injections, blood transfusion and catheterization which requires
disinfecting caps to avoid infection transfer. Furthermore, strict regulatory
standards and hygiene protocols in hospitals propel the demand for disinfecting
caps from this segment.
The diagnostic labs segment is the fastest growing segment in the market due to
rising number of diagnostic tests carried out for various health conditions.
Disinfecting caps are majorly utilized in collecting blood samples and ensuring
they remain free from contamination during transportation to labs.
PEST Analysis
Political: Strong regulatory environment pertaining to healthcare facility
hygiene and infection control in the U.S boosts demand. Government efforts to
expand health insurance coverage influence market growth.
Economic: Rising healthcare spending coupled with growing geriatric population
drives market expansion. Higher disposable incomes increase access to advanced
disinfection products.
Social: Increasing awareness about infection risks associated with needle-based
medical procedures and blood sampling favors adoption. Growing disease
incidence rate augments need for effective disinfection measures.
Technological: Advanced disinfecting caps with improved material and convenient
single-handed operation are gaining traction. Innovation in safety-engineered
medical devices heightens product utilization.
Key Takeaways
The U.S.
Disinfecting Cap Market Demand is expected to witness high growth over
the forecast period owing to rising cases of hospital-acquired infections.
Hospitals remain the dominant end-user segment supported by large patient
inflows and strict sterilization protocols. The global U.S. disinfecting cap
market is estimated to be valued at US$ 534.1 Mn in 2023 and is expected to
exhibit a CAGR of 10% over the forecast period 2023 to 2030.
Western
region commands the largest share due to presence of major medical hubs and
healthcare providers in states like California and Texas.
Key players operating in the U.S. Disinfecting Cap Market are ICU Medical, BD,
3M, Merit Medical Systems, Omnia Health, B. Braun SE, Agilent Technologies Inc.
Key players focus on new product launches catering to enhanced safety,
efficiency and user-friendliness. For instance, ICU Medical's CLAVE Clear
Disinfecting Cap system eliminates manual disinfection steps while ensuring
fluid pathway protection.
For more details on the report, Read- https://www.pressreleasebulletin.com/u-s-disinfecting-cap-market-size-and-share/
Comments
Post a Comment